Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 8.07% vs 17.28% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 22.52% vs -2.24% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 1.74% vs 17.81% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 0.42% vs 0.77% in Mar 2025
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
6.44
-3.35
-52.02%
Share Warrants & Outstandings
Total Reserve
65.09
19.32
45.77
236.90%
Shareholder's Funds
68.18
25.76
42.42
164.67%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.41
0.09
0.32
355.56%
Other Long Term Liabilities
0.00
0.57
-0.57
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.41
0.66
-0.25
-37.88%
Current Liabilities
Trade Payables
42.83
5.43
37.40
688.77%
Other Current Liabilities
2.28
1.30
0.98
75.38%
Short Term Borrowings
10.71
7.79
2.92
37.48%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
55.82
14.51
41.31
284.70%
Total Liabilities
124.42
40.93
83.49
203.98%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
18.80
10.53
8.27
78.54%
Less: Accumulated Depreciation
7.08
6.36
0.72
11.32%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
11.71
4.16
7.55
181.49%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.12
0.00
1.12
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.50
0.00
3.50
0.00%
Long Term Loans & Advances
0.83
5.10
-4.27
-83.73%
Other Non Current Assets
3.46
0.00
3.46
0.00%
Total Non-Current Assets
20.63
9.27
11.36
122.55%
Current Assets Loans & Advances
Current Investments
0.37
0.00
0.37
0.00%
Inventories
43.62
8.46
35.16
415.60%
Sundry Debtors
51.05
17.87
33.18
185.67%
Cash and Bank
6.00
2.21
3.79
171.49%
Other Current Assets
0.11
0.28
-0.17
-60.71%
Short Term Loans and Advances
2.64
2.85
-0.21
-7.37%
Total Current Assets
103.79
31.67
72.12
227.72%
Net Current Assets (Including Current Investments)
47.96
17.15
30.81
179.65%
Total Current Assets Excluding Current Investments
103.42
31.67
71.75
226.56%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
124.42
40.93
83.49
203.98%
Contingent Liabilities
0.91
0.00
0.91
0.00%
Total Debt
10.71
7.79
2.92
37.48%
Book Value per share (adjusted)
220.67
40.01
180.66
451.54%
Annual - Borrowings
Borrowings 10.71 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.07% vs 17.28% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 12.84 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 22.52% vs -2.24% in Mar 2025
Annual - Investments
Investments 3.50 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.74% vs 17.81% in Mar 2025
Annual - Current Assets
Current Assets 103.79 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.42% vs 0.77% in Mar 2025
Footer loading
